GuiZhou SanLi Pharmaceutical Co.,Ltd

SSE:603439.SS

12.16 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q12017 Q42017 Q32017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 408.589697.272521.295492.493417.426658.944338.843281.684348.978491.179280.35271.107158.681324.59237.395247.825129.156266.64981.656134.554147.365312.328223.41204.995143.05188.337111.274200.151200.15184.211159.225159.22598.0898.08108.825108.82570.69570.69574.79574.79558.64358.643
Cost of Revenue 140.344205.378153.66170.027128.677186.66982.6677.28596.311131.67178.08382.95246.79897.95966.74572.34239.96286.69728.21444.76349.305108.68174.36168.07447.6465.2738.13866.60866.60828.60554.16354.16335.79535.79540.47140.47127.35327.35328.2428.2422.50722.507
Gross Profit 268.246491.893367.635322.466288.749472.275256.183204.399252.667359.507202.267188.155111.882226.631170.651175.48389.194179.95253.44289.79198.061203.648149.048136.92195.41123.06873.136133.543133.54355.607105.062105.06262.28562.28568.35568.35543.34343.34346.55646.55636.13636.136
Gross Profit Ratio 0.6570.7050.7050.6550.6920.7170.7560.7260.7240.7320.7210.6940.7050.6980.7190.7080.6910.6750.6540.6670.6650.6520.6670.6680.6670.6530.6570.6670.6670.660.660.660.6350.6350.6280.6280.6130.6130.6220.6220.6160.616
Reseach & Development Expenses 7.41616.66412.4218.5278.89212.148.0595.3985.0146.5978.8051.4361.0245.1242.0840.3850.0892.6882.3240.5170.1021.5290.1461.836010.094000000000.0590.059000.0480.0480.0480.048
General & Administrative Expenses 39.833-82.163100.455-9.96127.525-30.87545.509-2.2915.643-18.18527.3370.7110.846-11.58921.079-2.7089.353-8.4395.753-0.055.535-10.1644.9575.895.8934.4824.2457.2397.2395.5845.4645.4643.3633.3633.1153.1151.9281.9282.4232.4231.9511.951
Selling & Marketing Expenses 164.576163.27283.222203.366179.184333.254158.237133.169168.023216.539141.484123.29181.307154.599116.586116.42763.224116.20342.85458.74758.947143.51597.72190.13962.56881.19954.15494.65894.65836.63377.78777.78741.43441.43448.91648.91629.56529.56534.28534.28525.89325.893
SG&A 204.40881.107261.117243.821206.986358.19203.746130.879183.667198.355168.822124.00192.153143.011137.665113.71972.577107.76448.60658.69864.482133.351102.67896.02968.46185.68158.399101.897101.89742.21883.25183.25144.79744.79751.80351.80331.49331.49336.70836.70827.84427.844
Other Expenses 9.177302.254-116.112-1.3940.247-1.677-1.039-0.642.46237.43-19.5760.028-0.066-0.005-2-0.167-0.37-0.1-0.050.057-2.2800.2231.661-0.00900000000000000000
Operating Expenses 221.001400.025279.986253.742215.631372.007191.707156.249191.142242.381158.051142.73794.646177.035126.732122.0273.151128.13152.06866.86566.187156.569104.68898.80170.19189.12540.18596.88996.88943.74381.01781.01742.69442.69451.52551.52530.12530.12537.01937.01928.81828.818
Operating Income 47.24591.86893.24368.72473.119100.26866.05354.41663.385112.35643.30545.54324.34546.87148.45755.61628.24853.1782.24924.26632.57745.15745.85838.14325.43835.3212.96528.65228.65211.60118.64118.64115.93715.93714.87414.87410.81410.8148.9588.9587.3467.346
Operating Income Ratio 0.1160.1320.1790.140.1750.1520.1950.1930.1820.2290.1540.1680.1530.1440.2040.2240.2190.1990.0280.180.2210.1450.2050.1860.1780.1880.1170.1430.1430.1380.1170.1170.1620.1620.1370.1370.1530.1530.120.120.1250.125
Total Other Income Expenses Net 0.655-0.1110.649-0.232-1.529-1.225-1.039-0.64-0.013-2.9740.0210.028-0.066-0.005-2-0.167-0.37-0.1-0.050.057-2.28001.1980-0.28219.37.8067.8060.1484.9974.9975.3335.3331.9611.9613.0913.0910.8920.892-0.023-0.023
Income Before Tax 47.991.75893.89271.79867.657150.7565.01453.77663.372109.38243.32645.57124.27946.86646.45755.4527.87853.0782.19924.32330.29745.15745.85839.34125.43834.44632.95137.02537.02511.86424.04524.04519.59119.59117.27717.27713.35513.35510.01210.0126.9816.981
Income Before Tax Ratio 0.1170.1320.180.1460.1620.2290.1920.1910.1820.2230.1550.1680.1530.1440.1960.2240.2160.1990.0270.1810.2060.1450.2050.1920.1780.1830.2960.1850.1850.1410.1510.1510.20.20.1590.1590.1890.1890.1340.1340.1190.119
Income Tax Expense 5.36310.70413.57610.19110.71714.4717.7286.9789.97512.8427.3816.0994.2999.2054.9059.5034.4377.7750.0293.724.4236.1396.8846.053.6515.2894.9435.6595.6591.8093.6333.6332.5642.5642.9322.9321.3951.3951.9771.9770.5180.518
Net Income 41.94779.89677.07261.01256.048134.73757.0246.01354.93397.64439.64840.26223.7340.35842.53645.94723.44145.3042.17120.60325.87539.01738.98433.29221.78729.15628.00831.36631.36610.05520.41320.41317.02717.02714.34514.34511.9611.968.0358.0356.4626.462
Net Income Ratio 0.1030.1150.1480.1240.1340.2040.1680.1630.1570.1990.1410.1490.150.1240.1790.1850.1810.170.0270.1530.1760.1250.1740.1620.1520.1550.2520.1570.1570.1190.1280.1280.1740.1740.1320.1320.1690.1690.1070.1070.110.11
EPS 0.10.1930.190.150.140.330.140.110.140.240.10.10.060.10.10.110.060.120.120.050.070.10.260.0910.0590.080.0760.0830.0830.0270.0570.0570.0550.0550.0510.0510.0750.0753.133.130.0240.024
EPS Diluted 0.10.1930.190.150.140.330.140.110.140.240.10.10.060.10.10.110.060.120.120.050.070.10.260.0910.0590.080.0760.0830.0830.0270.0570.0570.0550.0550.0510.0510.0750.0753.133.130.0240.024
EBITDA 51.09396.41893.60895.32182.959161.78674.76160.99772.285115.1845.58149.63127.92948.86248.43962.39930.46555.955.19725.46333.75947.32247.55240.01225.21936.36214.79930.52730.52713.34620.40820.40817.65917.65915.46415.46411.39411.3949.7479.7477.6257.625
EBITDA Ratio 0.1250.1380.180.1940.1990.2460.2210.2170.2070.2340.1630.1830.1760.1510.2040.2520.2360.210.0640.1890.2290.1520.2130.1950.1760.1930.1330.1530.1530.1580.1280.1280.180.180.1420.1420.1610.1610.130.130.130.13